Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
General Introduction | Zhongzhu Medical Holdings Co., Ltd., formerly known as Hubei Qianjiang Pharmaceutical Co., Ltd., was listed on the Shanghai Stock Exchange on May 18, 2001 (stock code: 600568). It is a national ophthalmic drug production base and a listed company in ophthalmic medicine. In recent years, the company has been brave in exploring and continuously practicing in the medical field, and has established a strategic goal of comprehensively advancing towards assisted reproduction, stem cell applications, tumor molecule targeted drugs, tumor diagnosis and treatment equipment, tumor diagnosis and treatment and rehabilitation. Its business covers three major fields: medical, pharmaceutical, and medical equipment. Through the integration of resources, the company has achieved rapid development. |
Headquarter | Qianjiang |
Establish Date | 6/27/1994 |
Listed Code | 600568.SH |
Listed Date | 5/18/2001 |
Chairman | Ye Jige. |
CEO | Wang Bo. |
Website | www.zz600568.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial